Page last updated: 2024-11-06

prednisolone and Pulmonary Arterial Remodeling

prednisolone has been researched along with Pulmonary Arterial Remodeling in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wong, C1
Bezhaeva, T1
Rothuizen, TC1
Metselaar, JM1
de Vries, MR1
Verbeek, FP1
Vahrmeijer, AL1
Wezel, A1
van Zonneveld, AJ1
Rabelink, TJ1
Quax, PH1
Rotmans, JI1

Other Studies

1 other study available for prednisolone and Pulmonary Arterial Remodeling

ArticleYear
Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model.
    Scientific reports, 2016, 07-27, Volume: 6

    Topics: Animals; Arteriovenous Fistula; CD3 Complex; Cells, Cultured; Cytokines; Disease Models, Animal; Inf

2016